THERANEXUS company press release from Update on the Theranexus' Batten-1 project in CLN3 Batten's disease A communication by ...

A communication by BBDF and Theranexus of the promising results of the Batten-1 Phase I/II trial at the Child Neurology ...

The failure of Eyenovia's CHAPERONE study has seen the company’s stock value drop drastically as it considers options and ...

Bitmap Books is a video game book publisher with a design-first mindset. This means that Bitmap's founder, creative ...

CVI is a spectrum of visual impairments caused by an underlying brain abnormality that affects the development of visual ...

Combining patching with active amblyopia interventions, such as vision therapy or perceptual learning, improves visual outcomes.

Experts convened by the National Institutes of Health (NIH) have identified five elements of a brain-based condition that has ...

Engage with this intriguing optical puzzle designed to test your visual acuity. Your primary objective is to scrutinize ...

In both TEASE-1 and TEASE-3, gildeuretinol demonstrated a favorable safety and tolerability profile. There were no adverse ...

Our commitment to the community has gotten better. Members of the Pampanga Press Club (PPC) no longer make themselves contented with seeing their bylines in var ...

LLRL therapy for high myopia can result in axial length shortening and more positive spherical equivalent refraction.

The screenings were conducted using Optec optical testing machines, assessing distance and near visual acuity. Each year ...